These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38404138)

  • 1. PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery.
    Kamya P; Ozerov IV; Pun FW; Tretina K; Fokina T; Chen S; Naumov V; Long X; Lin S; Korzinkin M; Polykovskiy D; Aliper A; Ren F; Zhavoronkov A
    J Chem Inf Model; 2024 May; 64(10):3961-3969. PubMed ID: 38404138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemistry42: An AI-Driven Platform for Molecular Design and Optimization.
    Ivanenkov YA; Polykovskiy D; Bezrukov D; Zagribelnyy B; Aladinskiy V; Kamya P; Aliper A; Ren F; Zhavoronkov A
    J Chem Inf Model; 2023 Feb; 63(3):695-701. PubMed ID: 36728505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine.
    Pun FW; Leung GHD; Leung HW; Liu BHM; Long X; Ozerov IV; Wang J; Ren F; Aliper A; Izumchenko E; Moskalev A; de Magalhães JP; Zhavoronkov A
    Aging (Albany NY); 2022 Mar; 14(6):2475-2506. PubMed ID: 35347083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of dual-purpose therapeutic targets implicated in aging and glioblastoma multiforme using PandaOmics - an AI-enabled biological target discovery platform.
    Olsen A; Harpaz Z; Ren C; Shneyderman A; Veviorskiy A; Dralkina M; Konnov S; Shcheglova O; Pun FW; Leung GHD; Leung HW; Ozerov IV; Aliper A; Korzinkin M; Zhavoronkov A
    Aging (Albany NY); 2023 Apr; 15(8):2863-2876. PubMed ID: 37100462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor.
    Ren F; Ding X; Zheng M; Korzinkin M; Cai X; Zhu W; Mantsyzov A; Aliper A; Aladinskiy V; Cao Z; Kong S; Long X; Man Liu BH; Liu Y; Naumov V; Shneyderman A; Ozerov IV; Wang J; Pun FW; Polykovskiy DA; Sun C; Levitt M; Aspuru-Guzik A; Zhavoronkov A
    Chem Sci; 2023 Feb; 14(6):1443-1452. PubMed ID: 36794205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics - An AI-Enabled Biological Target Discovery Platform.
    Pun FW; Liu BHM; Long X; Leung HW; Leung GHD; Mewborne QT; Gao J; Shneyderman A; Ozerov IV; Wang J; Ren F; Aliper A; Bischof E; Izumchenko E; Guan X; Zhang K; Lu B; Rothstein JD; Cudkowicz ME; Zhavoronkov A
    Front Aging Neurosci; 2022; 14():914017. PubMed ID: 35837482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-confidence cancer patient stratification through multiomics investigation of DNA repair disorders.
    Mkrtchyan GV; Veviorskiy A; Izumchenko E; Shneyderman A; Pun FW; Ozerov IV; Aliper A; Zhavoronkov A; Scheibye-Knudsen M
    Cell Death Dis; 2022 Nov; 13(11):999. PubMed ID: 36435816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery.
    Thomford NE; Senthebane DA; Rowe A; Munro D; Seele P; Maroyi A; Dzobo K
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29799486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How can artificial intelligence be used for peptidomics?
    Perpetuo L; Klein J; Ferreira R; Guedes S; Amado F; Leite-Moreira A; Silva AMS; Thongboonkerd V; Vitorino R
    Expert Rev Proteomics; 2021 Jul; 18(7):527-556. PubMed ID: 34343059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MolProphet: A One-Stop, General Purpose, and AI-Based Platform for the Early Stages of Drug Discovery.
    Yang K; Xie Z; Li Z; Qian X; Sun N; He T; Xu Z; Jiang J; Mei Q; Wang J; Qu S; Xu X; Chen C; Ju B
    J Chem Inf Model; 2024 Apr; 64(8):2941-2947. PubMed ID: 38563534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From GPUs to AI and quantum: three waves of acceleration in bioinformatics.
    Schmidt B; Hildebrandt A
    Drug Discov Today; 2024 Jun; 29(6):103990. PubMed ID: 38663581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying Artificial Intelligence to Identify Common Targets for Treatment of Asthma, Eczema, and Food Allergy.
    Liu HM; Rayner A; Mendelsohn AR; Shneyderman A; Chen M; Pun FW
    Int Arch Allergy Immunol; 2024; 185(2):99-110. PubMed ID: 37989115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial intelligence for drug discovery and development in Alzheimer's disease.
    Qiu Y; Cheng F
    Curr Opin Struct Biol; 2024 Apr; 85():102776. PubMed ID: 38335558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review on Deep Learning-driven Drug Discovery: Strategies, Tools and Applications.
    Sumathi S; Suganya K; Swathi K; Sudha B; Poornima A; Varghese CA; Aswathy R
    Curr Pharm Des; 2023 May; 29(13):1013-1025. PubMed ID: 37055908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial intelligence in drug design.
    Zhong F; Xing J; Li X; Liu X; Fu Z; Xiong Z; Lu D; Wu X; Zhao J; Tan X; Li F; Luo X; Li Z; Chen K; Zheng M; Jiang H
    Sci China Life Sci; 2018 Oct; 61(10):1191-1204. PubMed ID: 30054833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming drug discovery with a high-throughput AI-powered platform: A 5-year experience with Patrimony.
    Blaudin de Thé FX; Baudier C; Andrade Pereira R; Lefebvre C; Moingeon P;
    Drug Discov Today; 2023 Nov; 28(11):103772. PubMed ID: 37717933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive AI-driven analysis of large-scale omic datasets reveals novel dual-purpose targets for the treatment of cancer and aging.
    Pun FW; Leung GHD; Leung HW; Rice J; Schmauck-Medina T; Lautrup S; Long X; Liu BHM; Wong CW; Ozerov IV; Aliper A; Ren F; Rosenberg AJ; Agrawal N; Izumchenko E; Fang EF; Zhavoronkov A
    Aging Cell; 2023 Dec; 22(12):e14017. PubMed ID: 37888486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Industrializing AI-powered drug discovery: lessons learned from the
    Guedj M; Swindle J; Hamon A; Hubert S; Desvaux E; Laplume J; Xuereb L; Lefebvre C; Haudry Y; Gabarroca C; Aussy A; Laigle L; Dupin-Roger I; Moingeon P
    Expert Opin Drug Discov; 2022 Aug; 17(8):815-824. PubMed ID: 35786124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development.
    Sarkar C; Das B; Rawat VS; Wahlang JB; Nongpiur A; Tiewsoh I; Lyngdoh NM; Das D; Bidarolli M; Sony HT
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.